 |
인쇄하기
취소
|
‘The second Amosartan Naxozol, lead Hanmi growth for three years’
Published: 2013-11-07 06:57:00
Updated: 2013-11-07 06:57:00
Naxozol Product Manager Dae-Sung Kyung
(Digital BOSA)
‘Patient charge will reduce by 33% and surpass Celebrex reputation’
“Naxozol is a product that will drive the growth of Hanmi for the next three years. You can regard it as the second Amosartan,” said Dae-Sung Kyung, product manager of Hanmi who is in charge of Naxozol marketing.
He is confident about the quality of product couple...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.